Doctor's Guide
BALTIMORE, Md -- October 14, 2009 -- Interim data with donepezil administered to patients in the Mayo Acute Stroke Trial to Enhance Recovery (MASTER) supports advancement into stage 2, according to a report presented here at the American Neurological Association (ANA) 134th Annual Meeting.